Skip to main content
Signal8

WYNNEFIELD PARTNERS SMALL CAP VALUE LP I

SEC insider (Form 3/4/5 filer). CIK 0001251565. 10% Owner at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 3, 2024. Located in NEW YORK, NY.

Companies WYNNEFIELD PARTNERS SMALL CAP VALUE LP I has filed insider reports for

  • LIFECORE BIOMEDICAL, INC. \DE\ (LFCR): 10% Owner
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I profile photo

WYNNEFIELD PARTNERS SMALL CAP VALUE LP I

CIK: 0001251565

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LIFECORE BIOMEDICAL, INC. \DE\ logo
LFCR

LIFECORE BIOMEDICAL, INC. \DE\

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • LIFECORE BIOMEDICAL, INC. \DE\ logo
    LFCR

    LIFECORE BIOMEDICAL, INC. \DE\

    Oct 3, 2024
    Purchase
    Direct
    122.9K shares at avg. $4.10$504K
  • LIFECORE BIOMEDICAL, INC. \DE\ logo
    LFCR

    LIFECORE BIOMEDICAL, INC. \DE\

    Oct 3, 2024
    Purchase
    Indirect
    169.8K shares at avg. $4.10$696K

1-2 of 2